Organon & Co | Tillgångar



Assets Ändra Datum
Adcock Ingram Holdings ZAR 8.35B 25.86M 2024-06
Bristol-Myers Squibb USD 92.6B 1.07B 2024-12
Celltrion KRW 20.31T 180.03B 2024-09
Cspc Pharmaceutical CNY 44.39B 3.51B 2024-12
Dianthus Therapeutics USD 374.01M 19.76M 2024-12
Ecofibre AUD 71.25M 1.95M 2024-06
Gilead Sciences USD 59B 4.47B 2024-12
Glaxosmithkline GBP 59.46B 1.41B 2024-12
Kangmei Pharma CNY 14.19B 63.4M 2024-09
Knight Therapeutics CAD 962.29M 16.93M 2024-09
Laboratorios Farma EUR 832.02M 25.3M 2024-12
Malin Corporation EUR 128.4M 11.8M 2024-06
Medical Developments International AUD 59.16M 31.9M 2024-06
Merck USD 117.11B 426M 2024-12
Neuren Pharmaceuticals AUD 409.71M 181.55M 2024-12
Novartis USD 102.25B 1.28B 2024-12
Organigram Holdings CAD 479.21M 71.35M 2024-12
Organon & Co USD 13.1B 349M 2024-12
Pharma Mar EUR 349.64M 16.52M 2024-12
Qiagen NV USD 5.69B 580.57M 2024-12
Sartorius EUR 9.79B 148.6M 2024-09
Sino Biopharmaceutical CNY 65.41B 1.3B 2024-12
Tilray USD 4.19B 70.11M 2024-11



Organon & Co Tillgångar - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Apr 2025.